Liaoning Chengda Biotechnology Co.,Ltd. (SHA:688739)
China flag China · Delayed Price · Currency is CNY
24.20
-0.54 (-2.18%)
At close: May 12, 2026

SHA:688739 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3,6924,3654,4964,5485,7972,829
Short-Term Investments
--30.1260.19291.13270.72
Trading Asset Securities
1,399850.47973.021,094-3,316
Cash & Short-Term Investments
5,0915,2155,5005,7026,0886,416
Cash Growth
-5.83%-5.17%-3.55%-6.33%-5.12%194.49%
Accounts Receivable
1,0501,0491,0771,0821,111958.17
Other Receivables
1.891.871.4111.911.631.09
Receivables
1,0521,0511,0781,0941,113959.27
Inventory
472.37474.39459.94422.42479.88385.16
Prepaid Expenses
-----2.02
Other Current Assets
105.7946.3145.4730.125.1534.75
Total Current Assets
6,7216,7877,0837,2497,7067,798
Property, Plant & Equipment
1,8341,8771,9611,8851,4371,228
Long-Term Investments
33.55171.14132.37225.07258.56305.31
Other Intangible Assets
491.58182.02181.45178.87187.21123.35
Long-Term Deferred Tax Assets
36.2734.1635.7242.3930.2925.08
Long-Term Deferred Charges
321.8632.09588.54381.37187.4582.06
Other Long-Term Assets
237.1863.269.22120.21249.49231.61
Total Assets
9,6769,74610,05210,08110,0569,793
Accounts Payable
138.3112.195.2215.7616.333.1
Accrued Expenses
85.04178.91189.18158.48165.97176.43
Current Portion of Leases
-4.65.144.864.534.49
Current Income Taxes Payable
---26.9918.8624.17
Current Unearned Revenue
5.631.643.651.970.163.1
Other Current Liabilities
7.52103.3190.12148.7367.1277.72
Total Current Liabilities
236.49300.63393.31356.79272.99289.01
Long-Term Leases
4.834.771015.1417.421.91
Long-Term Unearned Revenue
72.6975.2785.6100.79111.1120.74
Long-Term Deferred Tax Liabilities
0.110.160.199.54.669.03
Other Long-Term Liabilities
9.1711.210.010.010.010.02
Total Liabilities
323.3392.05489.12482.23406.16440.72
Common Stock
416.45416.45416.45416.45416.45416.45
Additional Paid-In Capital
5,0345,0345,0345,0345,0345,034
Retained Earnings
4,0624,0644,2624,2484,1993,901
Treasury Stock
-160.78-160.78-149.99-99.99--
Shareholders' Equity
9,3529,3549,5629,5999,6509,352
Total Liabilities & Equity
9,6769,74610,05210,08110,0569,793
Total Debt
4.839.3715.1420.0121.9326.41
Net Cash (Debt)
5,0865,2065,4845,6826,0666,390
Net Cash Growth
-5.66%-5.08%-3.48%-6.33%-5.07%193.28%
Net Cash Per Share
12.5912.6413.2813.6614.5316.75
Filing Date Shares Outstanding
381.54411.25411.64412.86416.45416.45
Total Common Shares Outstanding
381.54411.25411.64413.47416.45416.45
Working Capital
6,4856,4866,6906,8927,4337,509
Book Value Per Share
24.5122.7523.2323.2223.1722.46
Tangible Book Value
8,8619,1729,3819,4209,4629,229
Tangible Book Value Per Share
23.2222.3022.7922.7822.7222.16
Buildings
-1,096992.14912.41713.81663.04
Machinery
-1,4921,4351,274880.16867.47
Construction In Progress
-427.4465.58438.82454.03210.84
Source: S&P Global Market Intelligence. Standard template. Financial Sources.